DM1 Heart Registry - DM1 Respiratory Registry
Cardiac and Respiratory Prognostic Factors in Patients With Myotonic Dystrophy Type 1
Sponsor: Institut de Myologie, France
Listed as NCT01136330, this observational or N/A phase trial focuses on Myotonic Dystrophy and remains completed. Sponsored by Institut de Myologie, France, it has been updated 6 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
▶ Show 1 earlier version
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
May 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Institut de Myologie, France
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Paris, France